The portal rektum.cz is dedicated mainly to the education of health care professionals on the issue of rectal cancer, which is diagnosed as C20 under the ICD-10 classification.
start of the project: 02/2010
end of the project: 01/2012
Each year about 8000 people are diagnosed with colorectal cancer in the Czech Republic, involving about 2000 cases of rectal cancer (C20 diagnosis). Despite the current possibilities of multimodal treatment, this type of cancer remains to be a serious illness with a mortality rate reaching up to 50%.
Expert teams of researchers and doctors from top-ranking medical facilities are fundamental for a right application of modern treatment possibilities. However, if the outcomes of research in cancer surgery and related findings in biostatistics are to be applied in clinical practice, an interdisciplinary education of healthcare professionals, students of oncology and of surgical disciplines, as well as experts in biostatistics is needed.
The project aims to ensure a further education of researchers in cancer surgery and of experts on biostatistics, with a particular emphasis on doctors-specialists from surgical departments and students involved in this area of research. This will be realized through an educational, research-oriented website, which will contain a database of patients diagnosed with rectal cancer.
The project is primarily aimed at the education of researchers and specialists working at the University Hospital in Motol, but it is also open to researchers from other hospitals and medical faculties in Prague (namely, the 1st and the 2nd Faculty of Medicine at Charles University in Prague).
The project will enhance the professional qualifications of target groups and will create preconditions for further cooperation among involved researchers. The Institute of Biostatistics and Analyses (IBA) at the Masaryk University in Brno is a partner of this project, building on many years of cooperation in the area of cancer research and biostatistics with the University Hospital in Motol and with experts from medical faculties at the Charles University in Prague.